Hsbc Holdings PLC Makes New $7.12 Million Investment in National Health Investors, Inc. $NHI

Hsbc Holdings PLC purchased a new position in National Health Investors, Inc. (NYSE:NHI) in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 93,376 shares of the real estate investment trust’s stock, valued at approximately $7,121,000.

A number of other hedge funds have also made changes to their positions in the stock. International Assets Investment Management LLC bought a new position in shares of National Health Investors in the 4th quarter valued at approximately $27,000. EverSource Wealth Advisors LLC boosted its position in National Health Investors by 244.1% during the second quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock worth $28,000 after purchasing an additional 288 shares during the period. Garton & Associates Financial Advisors LLC bought a new stake in National Health Investors during the fourth quarter worth approximately $33,000. Allworth Financial LP acquired a new position in National Health Investors during the second quarter valued at approximately $42,000. Finally, Advisory Services Network LLC acquired a new position in National Health Investors during the third quarter valued at approximately $65,000. Institutional investors and hedge funds own 62.51% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on NHI shares. Zacks Research cut shares of National Health Investors from a “hold” rating to a “strong sell” rating in a research note on Thursday, June 25th. Wells Fargo & Company lowered their target price on shares of National Health Investors from $84.00 to $79.00 and set an “equal weight” rating on the stock in a research note on Monday, June 1st. Deutsche Bank Aktiengesellschaft cut their target price on shares of National Health Investors from $85.00 to $80.00 and set a “hold” rating for the company in a research report on Thursday, June 25th. Truist Financial decreased their price target on shares of National Health Investors from $89.00 to $81.00 and set a “buy” rating for the company in a report on Friday, June 12th. Finally, BMO Capital Markets lowered their price target on National Health Investors from $90.00 to $80.00 and set an “outperform” rating on the stock in a research report on Monday, June 15th. Five equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, National Health Investors presently has a consensus rating of “Moderate Buy” and an average target price of $83.86.

Insider Buying and Selling

In other news, CEO D. Eric Mendelsohn bought 1,500 shares of the business’s stock in a transaction that occurred on Friday, June 5th. The stock was acquired at an average cost of $68.84 per share, for a total transaction of $103,260.00. Following the completion of the purchase, the chief executive officer owned 133,316 shares of the company’s stock, valued at $9,177,473.44. This trade represents a 1.14% increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Robert A. Mccabe, Jr. bought 890 shares of National Health Investors stock in a transaction that occurred on Monday, June 15th. The stock was purchased at an average cost of $71.65 per share, with a total value of $63,768.50. Following the completion of the transaction, the director owned 44,159 shares of the company’s stock, valued at $3,163,992.35. This trade represents a 2.06% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders own 2.70% of the company’s stock.

National Health Investors Stock Down 0.8%

NHI stock opened at $71.96 on Friday. National Health Investors, Inc. has a twelve month low of $67.94 and a twelve month high of $91.38. The company has a quick ratio of 6.78, a current ratio of 6.78 and a debt-to-equity ratio of 0.81. The company has a market cap of $3.53 billion, a PE ratio of 20.80, a price-to-earnings-growth ratio of 3.86 and a beta of 0.51. The business’s 50-day simple moving average is $75.68 and its 200 day simple moving average is $78.76.

National Health Investors (NYSE:NHI) last posted its quarterly earnings results on Monday, August 10th. The real estate investment trust reported $1.19 EPS for the quarter. National Health Investors had a return on equity of 10.89% and a net margin of 38.56%.The firm had revenue of $121.32 million during the quarter. During the same period last year, the company earned $1.22 EPS. The company’s revenue was up 1.6% on a year-over-year basis. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. On average, research analysts anticipate that National Health Investors, Inc. will post 4.78 earnings per share for the current year.

National Health Investors Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 6th. Stockholders of record on Wednesday, September 30th will be given a dividend of $0.92 per share. The ex-dividend date is Wednesday, September 30th. This represents a $3.68 dividend on an annualized basis and a dividend yield of 5.1%. National Health Investors’s payout ratio is currently 106.36%.

National Health Investors Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.